|
Mechanism5-HT2A receptor antagonists [+2] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CH |
First Approval Date15 Mar 1974 |
100 Clinical Results associated with United Heritage Life Insurance Co.
0 Patents (Medical) associated with United Heritage Life Insurance Co.
100 Deals associated with United Heritage Life Insurance Co.
100 Translational Medicine associated with United Heritage Life Insurance Co.